Strategic partnership Primordial Genetics is actively pursuing strategic collaborations, including a notable potential merger with Pelican Technology, which signals openness to joint ventures and co-development opportunities that can broaden product offerings and accelerate sales of enzyme and production systems.

Enzyme production focus The company emphasizes high-value enzyme-based production systems for manufacturing RNA and DNA, presenting a clear sales angle for enzymes, expression systems, and associated bioprocessing tools that support synthetic biology applications.

Bio-production growth With a mission to move away from fossil-based production toward a bio-economy, there is a market opportunity to position sustainability-aligned solutions, including scalable bioproduction platforms and renewable feedstock integration, to biotech manufacturers and pharma CDMOs.

Early-stage buying signals Past activities show collaborations with AI and energy labs, government/academic partnerships, and product launches like FOMO-21, indicating a receptiveness to new technology partnerships, licensing deals, and early access arrangements for novel enzymatic tools.

Global visibility and niche As a world-leading entity in constructive biology and a small team, there is an opportunity to offer high-impact, specialized solutions (custom enzymes, strain engineering, and bespoke production workflows) with a concierge sales approach targeting biotech firms seeking differentiation.